BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15929093)

  • 1. Premutations in the FMR1 gene as a modifying factor in Parkin-associated Parkinson's disease?
    Hedrich K; Pramstaller PP; Stübke K; Hiller A; Kabakci K; Purmann S; Kasten M; Scaglione C; Schwinger E; Volkmann J; Kostic V; Vieregge P; Martinelli P; Abbruzzese G; Klein C; Zühlke C
    Mov Disord; 2005 Aug; 20(8):1060-2. PubMed ID: 15929093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinsonism, FXTAS, and FMR1 premutations.
    Toft M; Aasly J; Bisceglio G; Adler CH; Uitti RJ; Krygowska-Wajs A; Lynch T; Wszolek ZK; Farrer MJ
    Mov Disord; 2005 Feb; 20(2):230-3. PubMed ID: 15390127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy.
    Moore CJ; Daly EM; Tassone F; Tysoe C; Schmitz N; Ng V; Chitnis X; McGuire P; Suckling J; Davies KE; Hagerman RJ; Hagerman PJ; Murphy KC; Murphy DG
    Brain; 2004 Dec; 127(Pt 12):2672-81. PubMed ID: 15483045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound heterozygosity at the FMR1 gene.
    Hegde MR; Fawkner M; Chong B; McGaughran J; Gilbert D; Love DR
    Genet Test; 2001; 5(2):135-8. PubMed ID: 11551100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A neuropsychological investigation of male premutation carriers of fragile X syndrome.
    Moore CJ; Daly EM; Schmitz N; Tassone F; Tysoe C; Hagerman RJ; Hagerman PJ; Morris RG; Murphy KC; Murphy DG
    Neuropsychologia; 2004; 42(14):1934-47. PubMed ID: 15381024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers.
    Kenneson A; Zhang F; Hagedorn CH; Warren ST
    Hum Mol Genet; 2001 Jul; 10(14):1449-54. PubMed ID: 11448936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragile X premutation alleles in SCA, ET, and parkinsonism in an Asian cohort.
    Tan EK; Zhao Y; Puong KY; Law HY; Chan LL; Yew K; Tan C; Shen H; Chandran VR; Teoh ML; Yih Y; Pavanni R; Wong MC; Ng IS
    Neurology; 2004 Jul; 63(2):362-3. PubMed ID: 15277639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screen for expanded FMR1 alleles in patients with essential tremor.
    Garcia Arocena D; Louis ED; Tassone F; Gilliam TC; Ottman R; Jacquemont S; Hagerman PJ
    Mov Disord; 2004 Aug; 19(8):930-3. PubMed ID: 15300658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FMR1 premutations associated with fragile X-associated tremor/ataxia syndrome in multiple system atrophy.
    Biancalana V; Toft M; Le Ber I; Tison F; Scherrer E; Thibodeau S; Mandel JL; Brice A; Farrer MJ; Dürr A
    Arch Neurol; 2005 Jun; 62(6):962-6. PubMed ID: 15956167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging study in older fragile X premutation male carriers.
    Loesch DZ; Litewka L; Brotchie P; Huggins RM; Tassone F; Cook M
    Ann Neurol; 2005 Aug; 58(2):326-30. PubMed ID: 16049924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation and intergenerational FMR1 CGG-repeat stability in 100 unrelated three-generation families from the normal population.
    Patsalis PC; Sismani C; Stylianou S; Ioannou P; Joseph G; Manoli P; Holden JJ; Hettinger JA
    Am J Med Genet; 1999 May; 84(3):217-20. PubMed ID: 10331595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association between FMR1 premutations and multiple system atrophy.
    Yabe I; Soma H; Takei A; Fujik N; Sasaki H
    J Neurol; 2004 Nov; 251(11):1411-2. PubMed ID: 15592742
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome.
    Taylor AK; Safanda JF; Fall MZ; Quince C; Lang KA; Hull CE; Carpenter I; Staley LW; Hagerman RJ
    JAMA; 1994 Feb; 271(7):507-14. PubMed ID: 8301764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population.
    Jacquemont S; Hagerman RJ; Leehey MA; Hall DA; Levine RA; Brunberg JA; Zhang L; Jardini T; Gane LW; Harris SW; Herman K; Grigsby J; Greco CM; Berry-Kravis E; Tassone F; Hagerman PJ
    JAMA; 2004 Jan; 291(4):460-9. PubMed ID: 14747503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations.
    Primerano B; Tassone F; Hagerman RJ; Hagerman P; Amaldi F; Bagni C
    RNA; 2002 Dec; 8(12):1482-8. PubMed ID: 12515381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screen for excess FMR1 premutation alleles among males with parkinsonism.
    Kraff J; Tang HT; Cilia R; Canesi M; Pezzoli G; Goldwurm S; Hagerman PJ; Tassone F
    Arch Neurol; 2007 Jul; 64(7):1002-6. PubMed ID: 17620491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of FMR1 gene expression in female premutation carriers using robust segmented linear regression models.
    García-Alegría E; Ibáñez B; Mínguez M; Poch M; Valiente A; Sanz-Parra A; Martinez-Bouzas C; Beristain E; Tejada MI
    RNA; 2007 May; 13(5):756-62. PubMed ID: 17449730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse mutations in the fragile X syndrome.
    Brown WT; Houck GE; Ding X; Zhong N; Nolin S; Glicksman A; Dobkin C; Jenkins EC
    Am J Med Genet; 1996 Aug; 64(2):287-92. PubMed ID: 8844067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragile X gene premutation in multiple system atrophy.
    Garland EM; Vnencak-Jones CL; Biaggioni I; Davis TL; Montine TJ; Robertson D
    J Neurol Sci; 2004 Dec; 227(1):115-8. PubMed ID: 15546601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragile X premutations are not a major cause of early menopause.
    Kenneson A; Cramer DW; Warren ST
    Am J Hum Genet; 1997 Dec; 61(6):1362-9. PubMed ID: 9399905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.